Company news
Anatara Lifesciences Ltd news in 2024
Anatara Lifesciences Ltd's news releases, calls and decks from 2024, newest first.
GaRP-IBS Clinical Trial Update
December 12, 2024
Share Purchase Plan Offer Booklet
November 26, 2024
Successful Placement of $660k and Share Purchase Plan
November 15, 2024
Chair's Address to Shareholders
November 14, 2024
Appendix 4C & Q1 FY25 Activities Report
October 31, 2024
GaRP-IBS Irritable Bowel Syndrome Clinical Trial Update
October 7, 2024
Anatara's GaRP granted EU patent
September 20, 2024
GaRP Irritable Bowel Syndrome Clinical Trial Update
August 29, 2024
$626,000 received in R&D Tax Incentive for FY24
August 28, 2024
Appendix 4E & Financial Report 30 June 2024
August 22, 2024
Appendix 4C & Q4 FY24 Activities Report
July 30, 2024
Anatara successful placement for $1.0M
May 1, 2024
Recruitment for Pivotal Phase II IBS Clinical Trial Stage 2
February 29, 2024
Appendix 4D & Half Year Report 31 December 2023
February 28, 2024
Appendix 4C & Q2 FY24 Activities Report
January 23, 2024
Decks in 2024
- Investor Presentation (December 2024)
Investor deck · 34 slides · Dec 2, 2024